FDA Puts a Boxed Liver-Injury Warning on Menopause Drug Veozah
Mahan Court, FDA White Oak Campus, White Oak, Montgomery County, Maryland, 20993, United States
Astellas Pharma
CONFIRMED87% CONFIDENCEThe FDA[1][5] drug safety communication carries the entry "12-16-2024 Update: FDA adds a Boxed Warning, our most prominent warning, to highlight the known risk of rare but serious liver injury".
The FDA adds a boxed warning, its most prominent, to Astellas' hot-flash pill Veozah after a patient suffered serious liver injury within about 40 days of starting it, and orders monthly liver tests for the first months.
1.00